Mackenzie Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-20,600
| Closed | -$596K | – | 1142 |
|
|
2019
Q4 | $596K | Buy |
20,600
+2,800
| +16% | +$81K | ﹤0.01% | 828 |
|
|
2019
Q3 | $460K | Buy |
17,800
+4,200
| +31% | +$109K | ﹤0.01% | 836 |
|
|
2019
Q2 | $347K | Buy |
+13,600
| New | +$347K | ﹤0.01% | 929 |
|
|
2018
Q4 | – | Sell |
-69,986
| Closed | -$1.65M | – | 1204 |
|
|
2018
Q3 | $1.65M | Sell |
69,986
-584
| -0.8% | -$13.8K | ﹤0.01% | 678 |
|
|
2018
Q2 | $1.63M | Buy |
70,570
+5,780
| +9% | +$133K | ﹤0.01% | 619 |
|
|
2018
Q1 | $1.6M | Buy |
64,790
+17,662
| +37% | +$435K | ﹤0.01% | 593 |
|
|
2017
Q4 | $1.27M | Buy |
47,128
+9,284
| +25% | +$249K | ﹤0.01% | 579 |
|
|
2017
Q3 | $911K | Sell |
37,844
-41,458
| -52% | -$998K | ﹤0.01% | 453 |
|
|
2017
Q2 | $1.7M | Sell |
79,302
-15,568
| -16% | -$334K | 0.01% | 397 |
|
|
2017
Q1 | $1.63M | Buy |
94,870
+43,178
| +84% | +$740K | 0.01% | 416 |
|
|
2016
Q4 | $927K | Buy |
+51,692
| New | +$927K | 0.01% | 448 |
|